What is Gyre Therapeutics, Inc.'s income tax?

Gyre Therapeutics, Inc. (GYRE) reported income tax of $621K in Q1 2026.

How has Gyre Therapeutics, Inc.'s income tax changed year-over-year?

Gyre Therapeutics, Inc.'s income tax decreased by 31.1% year-over-year, from $901K to $621K.

What is the long-term trend for Gyre Therapeutics, Inc.'s income tax?

Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s income tax has grown at a -3.7% compound annual growth rate (CAGR), from $5.1M to $4.56M.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Gyre Therapeutics, Inc. GYRE Income Tax

Income Tax at other companies

Eli LillyLLY

$1.45B+109%

Theravance BiopharmaTBPH

-$1.54M-175%

Rigel PharmaceuticalsRIGL

$3M+4,520%

Zevra Therapeutics, Inc.ZVRA

$6.91M+485%

LQD

Liquidia CorporationLQDA

$3.92M—

Opko HealthOPK

-$6.11M-5.9%

Segments

By segment

See full

Gyre Pharmaceuticals$621K-31.1%

All Other Segments$0—

Gyre$0—

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s income tax?: Gyre Therapeutics, Inc. (GYRE) reported income tax of $621K in Q1 2026.
How has Gyre Therapeutics, Inc.'s income tax changed year-over-year?: Gyre Therapeutics, Inc.'s income tax decreased by 31.1% year-over-year, from $901K to $621K.
What is the long-term trend for Gyre Therapeutics, Inc.'s income tax?: Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s income tax has grown at a -3.7% compound annual growth rate (CAGR), from $5.1M to $4.56M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.